Herantis Pharma
1.385 EUR -0.36%4,041 investors are following this company
Revenue
-
EBIT %
-
P/E
69.25
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
HRTIS
Daily low / high price
1.385 / 1.4
EUR
Market cap
27.92M EUR
Turnover
2.06K EUR
Volume
1.5K
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Skandinaviska Enskilda Banken | 18.6 % | 18.6 % |
Joensuun kauppa ja kone Oy | 9.8 % | 9.8 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Tone Kvåle | 2024-01-25 | 7,500EUR |
Tone Kvåle | 2022-06-01 | 7,140EUR |
Premium
This content is for our Premium customers only.
ShowingAll content types
Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders
Herantis Pharma participating at Alzheimer’s & Parkinson’s Drug Development Summit in Boston and Nordic Health Summit Japan.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools